Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP

NCT06727357 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer, Metastatic Breast Cancer

Interventions

DRUG: Chemotherapy

Sponsor

European Institute of Oncology